Table V.
Blood examination results at week 12.
| Treatment (n=19) | Placebo (n=16) | P-value | |
|---|---|---|---|
| ALT, IU/la | 28.68±13.10 | 23.00±16.26 | 0.327 |
| AST, IU/la | 23.84±7.24 | 19.88±6.20 | 0.094 |
| r-GT, U/la | 48.63±68.47 | 23.94±19.90 | 0.148 |
| BUN, mg/dlb | 14.18 (4.26) | 13.80 (2.87) | 0.694 |
| Creatinine, mg/dla | 0.71±0.14 | 0.73±0.14 | 0.766 |
| Iron, mg/dla | 104.89±35.21 | 111.63±41.08 | 0.605 |
| Ferritin, ng/mla | 160.00±107.79 | 215.30±150.61 | 0.215 |
| WBC, 103/mm3 b | 6.79 (2.60) | 5.69 (0.92) | 0.055 |
| RBC, million/mm3 b | 5.06 (0.56) | 4.89 (0.46) | 0.097 |
| Hb, g/dlb | 15.40 (1.40) | 14.60 (2.05) | 0.289 |
| Hct, %b | 43.90 (4.70) | 42.45 (4.25) | 0.360 |
| DHEA, ng/mlb | 214.60 (87.20) | 212.60 (151.60) | 0.987 |
| Testosterone, ng/mla | 3.06±1.84 | 3.13±1.88 | 0.908 |
| Estradiol, ng/mla | 52.82±42.54 | 45.37±19.45 | 0.501 |
a
Mean ± standard deviation
b
median (interquartile range). ALT, alanine aminotranferease; AST, aspartate aminotransferase; r-GT, gamma-glutamyl transpeptidase; BUN, blood urea nitrogen; WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; Hct, hematocrit; DHEA, dehydroepiandrosterone.